People with type 2 diabetes , for example, tend to lose weight more slowly on semaglutide and other GLP-1 medications
For more reliable weight loss outcomes and better safety assurance, FDA-approved Wegovy is recommended when accessible through insurance coverage or patient assistance programs
Your appetite quieted down, your energy levels stabilized, and the scale finally began to move
Most people regain 60-80% of lost weight within 12 months without medication
"The significant reduction in risk of composite endpoint of heart attack, stroke, or death seen in the SOUL trial in adults with type 2 diabetes highlights the cardiovascular impact of oral semaglutide in adult patients with cardiometabolic conditions such as type 2 diabetes and atherosclerotic cardiovascular disease and/or chronic kidney disease," said Dr John B Buse, Distinguished Professor of Medicine, Director of UNC Diabetes Care Center, Steering Committee Co-Chair of the SOUL trial